Cell, Animal and Imaging Core
Cell, Animal and Imaging Core
批准号:
7728884
负责人:
THERESA A GUISE
金额:
$12.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2010-07-31
关键词:
American Type Culture CollectionAnimal ExperimentsAnimal ModelAnimalsBehaviorBiological AssayBladderBone neoplasmsCell LineCell physiologyCellsCellular StructuresCommon NeoplasmCultured CellsDataData QualityDatabasesDetectionDocumentationEndothelial CellsEquipmentFingerprintFirefly LuciferasesFreezingGenetic screening methodGoalsGuidelinesHistologyHousingHuman Cell LineHuman ResourcesImageImage AnalysisInjection of therapeutic agentInstructionLaboratoriesLeadLifeLuciferasesMalignant neoplasm of prostateManuscriptsMetastatic Neoplasm to the BoneMicroscopyModalityMorphologyMusMycoplasmaNatureNeoplasm MetastasisOrchiectomyOrgan Culture TechniquesOsteoblastsOsteoclastsOsteolyticPhenotypeProceduresProcessProstateReagentReporterResearchResearch PersonnelResourcesRiskSamplingSourceStandardizationStandards of Weights and MeasuresSystemTechniquesTestingTissuesTraining ProgramsTumor-DerivedXenograft ModelXenograft procedureangiogenesisbaseboneexperienceimmortalized cellimprovedin vivomacromoleculemembermouse modelneoplastic cellprogramspromoterrepositorysingle cell analysissubcutaneoustissue culturetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Program makes extensive use of human cell lines and animal models of prostate cancer. The overall goal of
this Core is to provide materials, instructional support, technical aid,/n vivo imaging of mouse models of prostate
cancer metastases, and ex-vivo assays of tumor-bone interactions to Project investigators. This will encompass
the storage and distribution of well-characterized prostate cell lines and xenografts; the storage and distribution of
reporter and inducible cell lines; and instruction, guidelines and assistance with xenograft studies, Xenogen and
Faxitron imaging and assays for osteoblast, osteoclast and angiogenesis. Such standardization of cell culture
reagents and animal techniques will facilitate research by improving the quality of the data, reducing redundancy
and allowing comparison of results between the all Projects. This Core will have 5 Aims: 1) Provide wellcharacterized
prostate cancer and normal prostate cell lines to investigators and house a repository of all common
tumor and immortalized cell lines. In addition, the Core will carry out mycoplasma testing and genetic
fingerprinting (SNP analysis and/or VNTRs) of all cell lines received by Program investigators from outside
sources. Thus, any cell line received by an investigator will first be processed by the Core in this way and a
sample frozen in the repository. The Core will also serve as a repository of new cell lines derived by Program
investigators such as those with inducible promoters (S. Parsons, Weber) or with imaging capability such as those
containing transfected luciferase constructs (Theodorescu). 2) Provide live instruction and guidelines for
investigators using xenograft models such as those derived after subcutaneous, intracardiac, intrafemoral and
intraprostatic injection of tumor cells and with procedures such as orchiectomy. Instructional videos will be made
of these procedures and saved on a central server database (PROSTA, Core A) accessible by all Program
members via standard networked PCs. 3) Support for in vivo fluorescent imaging of tumors and Faxitron
radiographic imaging and quantitation of bone metastases will be provided by the Core. Technical help will involve
providing instruction as well as taking animals to the UVA SAMMIC core for MS (Xenogen Corp.) imaging of
tumors expressing luciferase. 4) Assessment of tumor-bone interactions will be performed using wellcharacterized
assays of osteoblast, osteoclast and endothelial cell function. 5) Microscopy Imaging: a) Resources
for the routine analysis and documentation of cell structure and morphology and the detection of macromolecules
in fixed, live cells and tissues; b) resources for single cell analysis; and c) training for Program personnel and
overall oversight of Core equipment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
-
批准号:9486907
-
项目类别:
-
资助金额:$63.07万
-
财政年份:2016
-
负责人:THERESA A GUISE
-
依托单位:
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
-
批准号:9935202
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2016
-
负责人:THERESA A GUISE
-
依托单位:
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
-
批准号:10328409
-
项目类别:
-
资助金额:$60.06万
-
财政年份:2016
-
负责人:THERESA A GUISE
-
依托单位:
PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
-
批准号:6918192
-
项目类别:
-
资助金额:$35.81万
-
财政年份:2005
-
负责人:THERESA A GUISE
-
依托单位:
PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
-
批准号:7212216
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2005
-
负责人:THERESA A GUISE
-
依托单位:
ENDOTHELIN-1 IN NORMAL AND PATHOLOGICAL BONE REMODELING
-
批准号:7336763
-
项目类别:
-
资助金额:$5.24万
-
财政年份:2005
-
负责人:THERESA A GUISE
-
依托单位:
PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
-
批准号:7032983
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2005
-
负责人:THERESA A GUISE
-
依托单位:
ENDOTHELIN-1 IN NORMAL AND PATHOLOGICAL BONE REMODELING
-
批准号:7005690
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2005
-
负责人:THERESA A GUISE
-
依托单位:
PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
-
批准号:7391126
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2005
-
负责人:THERESA A GUISE
-
依托单位:
ENDOTHELIN-1 IN NORMAL AND PATHOLOGICAL BONE REMODELING
-
批准号:6868304
-
项目类别:
-
资助金额:$30.47万
-
财政年份:2005
-
负责人:THERESA A GUISE
-
依托单位:
ENDOTHELIN-1 IN NORMAL AND PATHOLOGICAL BONE REMODELING
-
批准号:7158602
-
项目类别:
-
资助金额:$28.92万
-
财政年份:2005
-
负责人:THERESA A GUISE
-
依托单位:
PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
-
批准号:7610977
-
项目类别:
-
资助金额:$15.52万
-
财政年份:2005
-
负责人:THERESA A GUISE
-
依托单位:
PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
-
批准号:8068496
-
项目类别:
-
资助金额:$17.95万
-
财政年份:2005
-
负责人:THERESA A GUISE
-
依托单位:
Molecular mechanisms of osteoblastic bone metastasis: Role of endothelin-1
-
批准号:6314026
-
项目类别:
-
资助金额:$18.15万
-
财政年份:2000
-
负责人:THERESA A GUISE
-
依托单位:
Molecular mechanisms of osteoblastic bone metastasis: Role of endothelin-1
-
批准号:6203092
-
项目类别:
-
资助金额:$18.15万
-
财政年份:1999
-
负责人:THERESA A GUISE
-
依托单位:
Breast Cancer Osteolysis--Regulation of PTHrP by TGFBeta
-
批准号:6879970
-
项目类别:
-
资助金额:$26.19万
-
财政年份:1996
-
负责人:THERESA A GUISE
-
依托单位:
TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASIS
-
批准号:7388004
-
项目类别:
-
资助金额:$27.61万
-
财政年份:1996
-
负责人:THERESA A GUISE
-
依托单位:
Breast Cancer Osteolysis--Regulation of PTHrP by TGFBeta
-
批准号:6512793
-
项目类别:
-
资助金额:$7.16万
-
财政年份:1996
-
负责人:THERESA A GUISE
-
依托单位:
TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASIS
-
批准号:7740167
-
项目类别:
-
资助金额:$28.06万
-
财政年份:1996
-
负责人:THERESA A GUISE
-
依托单位:
BREAST CANCER METASTASES TO BONE--ROLE OF PTHRP & TGFB
-
批准号:2683627
-
项目类别:
-
资助金额:$10.15万
-
财政年份:1996
-
负责人:THERESA A GUISE
-
依托单位:
海外基金